PL2193793T3 - Inhibitor śmierci komórek nerwowych - Google Patents
Inhibitor śmierci komórek nerwowychInfo
- Publication number
- PL2193793T3 PL2193793T3 PL08836702T PL08836702T PL2193793T3 PL 2193793 T3 PL2193793 T3 PL 2193793T3 PL 08836702 T PL08836702 T PL 08836702T PL 08836702 T PL08836702 T PL 08836702T PL 2193793 T3 PL2193793 T3 PL 2193793T3
- Authority
- PL
- Poland
- Prior art keywords
- cell death
- nerve cell
- death inhibitor
- inhibitor
- nerve
- Prior art date
Links
- 230000030833 cell death Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 210000002569 neuron Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007259682 | 2007-10-03 | ||
| EP08836702A EP2193793B1 (en) | 2007-10-03 | 2008-10-02 | Nerve cell death inhibitor |
| PCT/JP2008/002768 WO2009044547A1 (ja) | 2007-10-03 | 2008-10-02 | 神経細胞死抑制剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2193793T3 true PL2193793T3 (pl) | 2012-12-31 |
Family
ID=40525979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08836702T PL2193793T3 (pl) | 2007-10-03 | 2008-10-02 | Inhibitor śmierci komórek nerwowych |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7973053B2 (pl) |
| EP (1) | EP2193793B1 (pl) |
| JP (1) | JP5399909B2 (pl) |
| KR (1) | KR101503782B1 (pl) |
| CN (1) | CN101815517A (pl) |
| CA (1) | CA2701397C (pl) |
| CY (1) | CY1113364T1 (pl) |
| DK (1) | DK2193793T3 (pl) |
| ES (1) | ES2389392T3 (pl) |
| PL (1) | PL2193793T3 (pl) |
| PT (1) | PT2193793E (pl) |
| TW (1) | TWI432195B (pl) |
| WO (1) | WO2009044547A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3481092T3 (pl) | 2016-06-29 | 2022-12-12 | Beijing Xiaomi Mobile Software Co., Ltd. | Sposób i urządzenie do przesyłania danych oraz terminal |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| JP2569746B2 (ja) | 1987-08-20 | 1997-01-08 | 日産化学工業株式会社 | キノリン系メバロノラクトン類 |
| JP3992806B2 (ja) | 1997-12-12 | 2007-10-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ドネペジル中間体の製造法 |
| JP4022332B2 (ja) | 1998-01-16 | 2007-12-19 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ドネペジル誘導体の製造法およびその中間体 |
| US6080778A (en) | 1998-03-23 | 2000-06-27 | Children's Medical Center Corporation | Methods for decreasing beta amyloid protein |
| US6472421B1 (en) * | 1998-11-13 | 2002-10-29 | Nymox Corporation | Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor |
| CA2389973A1 (en) | 1999-11-04 | 2001-05-10 | Andrx Corporation | Method of treating amyloid beta precursor disorders |
| US20020028826A1 (en) | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
| CA2437480A1 (en) | 2001-02-05 | 2002-08-15 | Andrx Corporation | Method of treating amyloid .beta. precursor disorder |
| ATE331523T1 (de) | 2002-04-02 | 2006-07-15 | Janssen Pharmaceutica Nv | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion |
| JP2006520368A (ja) * | 2003-03-19 | 2006-09-07 | アレス トレーディング ソシエテ アノニム | アルツハイマー病の治療 |
| ATE535614T1 (de) | 2003-12-30 | 2011-12-15 | Kowa Co | Screening-verfahren fuer gamma-sekretase- inhibitoren |
| JP2007532624A (ja) * | 2004-04-14 | 2007-11-15 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アルツハイマー病の治療のための療法組合せ |
| KR101436644B1 (ko) | 2006-01-31 | 2014-09-01 | 코와 가부시키가이샤 | 당뇨병 치료제 |
-
2008
- 2008-09-30 TW TW097137428A patent/TWI432195B/zh not_active IP Right Cessation
- 2008-10-02 KR KR1020107006970A patent/KR101503782B1/ko not_active Expired - Fee Related
- 2008-10-02 ES ES08836702T patent/ES2389392T3/es active Active
- 2008-10-02 PL PL08836702T patent/PL2193793T3/pl unknown
- 2008-10-02 PT PT08836702T patent/PT2193793E/pt unknown
- 2008-10-02 CN CN200880109935A patent/CN101815517A/zh active Pending
- 2008-10-02 JP JP2009535978A patent/JP5399909B2/ja not_active Expired - Fee Related
- 2008-10-02 DK DK08836702.4T patent/DK2193793T3/da active
- 2008-10-02 CA CA2701397A patent/CA2701397C/en not_active Expired - Fee Related
- 2008-10-02 US US12/676,265 patent/US7973053B2/en not_active Expired - Fee Related
- 2008-10-02 EP EP08836702A patent/EP2193793B1/en not_active Not-in-force
- 2008-10-02 WO PCT/JP2008/002768 patent/WO2009044547A1/ja active Application Filing
-
2012
- 2012-10-31 CY CY20121101047T patent/CY1113364T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2701397C (en) | 2015-11-03 |
| US7973053B2 (en) | 2011-07-05 |
| PT2193793E (pt) | 2012-09-28 |
| EP2193793A4 (en) | 2011-02-09 |
| JPWO2009044547A1 (ja) | 2011-02-03 |
| EP2193793B1 (en) | 2012-08-01 |
| TW200918059A (en) | 2009-05-01 |
| US20100173938A1 (en) | 2010-07-08 |
| KR101503782B1 (ko) | 2015-03-18 |
| TWI432195B (zh) | 2014-04-01 |
| KR20100072227A (ko) | 2010-06-30 |
| EP2193793A1 (en) | 2010-06-09 |
| ES2389392T3 (es) | 2012-10-25 |
| CY1113364T1 (el) | 2016-06-22 |
| DK2193793T3 (da) | 2012-08-20 |
| JP5399909B2 (ja) | 2014-01-29 |
| CN101815517A (zh) | 2010-08-25 |
| CA2701397A1 (en) | 2009-04-09 |
| WO2009044547A1 (ja) | 2009-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL221851A0 (en) | Targeted cell death | |
| GB0720484D0 (en) | Cells | |
| PL2361922T3 (pl) | Produkty pośrednie do wytwarzania inhibitorów nukleozydowych HCV | |
| GB0714485D0 (en) | Stimulator | |
| IL196134A0 (en) | Cell death inducer | |
| EP2069477A4 (en) | CHEMOREPULSION OF CELLS | |
| GB2454508B (en) | Electrode structures | |
| ZA201100797B (en) | Electrodepositable composition | |
| GB0700361D0 (en) | Pack | |
| TWI372862B (en) | Reference electrode | |
| ZA200908588B (en) | Pack | |
| PL2193793T3 (pl) | Inhibitor śmierci komórek nerwowych | |
| EP2191261A4 (en) | ELECTRODE | |
| GB0714941D0 (en) | Inhibitors | |
| GB0720292D0 (en) | Equation solving | |
| EP2253636A4 (en) | INHIBITOR OF NEURONAL CELL DEATH | |
| GB0605548D0 (en) | Cell inhibitor | |
| GB0713152D0 (en) | Phosphodlesterase inhibitors | |
| GB0720364D0 (en) | Inhibitor | |
| GB0700936D0 (en) | Cells | |
| GB0708483D0 (en) | Electrodes | |
| ZA200805575B (en) | Land electrode | |
| PL380136A1 (pl) | Ogniwo fotowoltaiczne | |
| GB0707499D0 (en) | Novel inhibitors | |
| GB0704589D0 (en) | Novel inhibitors |